Experimental cancer therapy tested in just one patient
Disease control
Terminated
This early-phase trial tested a new cell therapy for people with advanced solid tumors that have a specific marker called ALPP. The treatment uses the patient's own immune cells, modified to attack the cancer. Only one person took part before the study was stopped early, and the …
Phase: EARLY_PHASE1 • Sponsor: Haifeng Qin • Aim: Disease control
Last updated May 08, 2026 23:02 UTC